COVID-19 Disease Clinical Manifestations and Treatment Result Analysis

Youngah Choi; Jeong-Seon Yoo; Eun-Hyang Song; Bu-Yeon Kim; Shin-Ae Park; Hyun-Joo Jin

doi:doi:10.11648/j.sjcm.20221101.14

| Peer-Reviewed

COVID-19 Disease Clinical Manifestations and Treatment Result Analysis

Youngah Choi, Jeong-Seon Yoo, Eun-Hyang Song, Bu-Yeon Kim, Shin-Ae Park, Hyun-Joo Jin

Published in Science Journal of Clinical Medicine (Volume 11, Issue 1)

Received: 6 January 2022 Accepted: 21 January 2022 Published: 16 February 2022

Views: Downloads:

Download PDF

Share This Article

Twitter
Linked In
Facebook

Abstract

From March 2nd, 2020th, this hospital started as a hospital mainly for COVID-19 infections and has been continuously treating COVID-19 inpatients until now, January 5^th, 2022th. From the beginning of February, 2020th, to January 5^th, 2022th, the total cumulative number of confirmed COVID-19 cases in Korea was 649,669, the death toll was 5,838, and the mortality rate was 0.89%. The Korean quarantine system hospitalizes COVID-19 patients in the early stages of the (COVID-19) disease. We believe that it is due to this system that Korea has been able to keep a considerably low death rate compared to many other countries. In this paper, with data on 2,925 patients hospitalized from March 2, 2020 to September 30, 2021 at this hospital, this paper analyzes the disease patterns of patients, by analyzing clinical features and medication history of the patients and the existing diseases of the COVID-19 patients who were hospitalized in the hospital. The important thing is that Regdanvimab (Regkirona) should administered as early as possible in the early stage of infection and Veklury (Remdesivir) also should be administered as soon as possible at the time when oxygen saturation starts to drop. It is believed that the current quarantine system in Korea, which allows patients to be treated in hospitals at the initial stage of diagnosis, lowered the death rate from COVID-19.

Published in	Science Journal of Clinical Medicine (Volume 11, Issue 1)
DOI	10.11648/j.sjcm.20221101.14
Page(s)	25-32
Creative Commons	This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited.
Copyright	Copyright © The Author(s), 2024. Published by Science Publishing Group

Keywords

Antiviral Drug, Monoclonal Antibody, Redganvimab and Veklury

References

[1]	COVID-19 and Endocrine System: A Comprehensive Review on the Theme, Journal of Clinical Medicine, 2021, 10, 2920 Giuseppe Lisco etc.
[2]	SARS-CoV-2 and Acute Cerebrovascular Events: An Overview, Journal of Clinical Medicine, 2021, 10, 3349, Mehdi Ghasemi etc.
[3]	The Rheumatology Drugs for COVID-19 Management: Which and When? Journal of Clinical Medicine, 2021, 10, 783, Fabiola Atzeni etc.
[4]	The Role of Neuropilin-1 (NRP-1) in SARS-CoV-2 infection: Review Journal of Clinical Medicine, 2021, 10, 2772, Monika Gudowska-Sawcwuk etc.
[5]	A state –of-the-Art Survey on Artificial Intelligence to Fight COVID-19, Journal of Clinical medicine, 2021, 10, 1961, Md. Mohaimenul Islam etc.
[6]	Arginas1 (ARG1) as an Up-Regulated Gene in COVID-19 Patients: A Promising Marker in COVID-19 Immunopathy, Journal of Clinical medicine, 2021, 10, 1051, Afshin Derakhshani etc.
[7]	Spontaneous Pneumomediastinum, Pneumothorax, Pneumopericardium and Subcutaneous Emphysema – Not So Uncommon Comlications in Patients with COVID-19 Pulmonary Infection – A Series of Cases, Journal of Clinical Medicine, 2021, 10, 1346, Talida Georgiana Cut etc.
[8]	Statin Use Is Associated with a Decreased Risk of Mortality among Patients with COVID-19. Journal of Clinical Medicine, 2021, 10, 1450, Chieh-Chen Wu etc.
[9]	One Year after Mild COVID-19; The Majority of Patients Maintain Specific Immunity, But One in Four Still Suffer from Long term Symptoms. Journal of Clinical Medicine, 2021, 10, 3305, Andreas Rank etc.
[10]	Risk Factors for Mortality in Adult COVID-19 Patients Who Develop Bloodstream Infections Mostly Caused by Antimicrobial-Resistant Organisms: Analysis at a Large Teaching Hospital in Italy, Journal of Clinical Medicine, 2021, 10, 1752, Brunella Posteraro etc.
[11]	Ciclesonide Inhaler Treatment for Mild-to-Moderate COVID-19: A Randomized, Open-Label, Phase 2 Trial, Journal of Clinical Medicine, 2021, 10, 3545, Joon-Young Song etc.
[12]	Patient Characteristics and Clinical Course of COVID-19 Patients Treated at a German Tertiary Center during the First and Second Waves in the Year 2020, Journal of Clinical Medicine, 2021, 10, 2274, Thomas Theo Brehm etc.
[13]	Clinical Implications of Neurological Comorbidities and Complications in ICU patients with COVID-19. Journal of Clinical Medicne, 2021, 10, 2281, Jaeseok Park etc.
[14]	Article: The Importance of Early Treatment for COVID-19, Americal Journal of Biomedical Science & Research, September 24, 2021, Youngah Choi etc.
[15]	National Institute of Infectious Diseases, Central Clinical Committee for Emerging Infectious Diseases, COVID-19 treatment recommendation (ver 2.0).

Cite This Article

Plain Text BibTeX RIS

APA Style

Youngah Choi, Jeong-Seon Yoo, Eun-Hyang Song, Bu-Yeon Kim, Shin-Ae Park, et al. (2022). COVID-19 Disease Clinical Manifestations and Treatment Result Analysis. Science Journal of Clinical Medicine, 11(1), 25-32. https://doi.org/10.11648/j.sjcm.20221101.14

Copy | Download

ACS Style

Youngah Choi; Jeong-Seon Yoo; Eun-Hyang Song; Bu-Yeon Kim; Shin-Ae Park, et al. COVID-19 Disease Clinical Manifestations and Treatment Result Analysis. Sci. J. Clin. Med. 2022, 11(1), 25-32. doi: 10.11648/j.sjcm.20221101.14

Copy | Download

AMA Style

Youngah Choi, Jeong-Seon Yoo, Eun-Hyang Song, Bu-Yeon Kim, Shin-Ae Park, et al. COVID-19 Disease Clinical Manifestations and Treatment Result Analysis. Sci J Clin Med. 2022;11(1):25-32. doi: 10.11648/j.sjcm.20221101.14

Copy | Download

@article{10.11648/j.sjcm.20221101.14,
  author = {Youngah Choi and Jeong-Seon Yoo and Eun-Hyang Song and Bu-Yeon Kim and Shin-Ae Park and Hyun-Joo Jin},
  title = {COVID-19 Disease Clinical Manifestations and Treatment Result Analysis},
  journal = {Science Journal of Clinical Medicine},
  volume = {11},
  number = {1},
  pages = {25-32},
  doi = {10.11648/j.sjcm.20221101.14},
  url = {https://doi.org/10.11648/j.sjcm.20221101.14},
  eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.sjcm.20221101.14},
  abstract = {From March 2nd, 2020th, this hospital started as a hospital mainly for COVID-19 infections and has been continuously treating COVID-19 inpatients until now, January 5th, 2022th. From the beginning of February, 2020th, to January 5th, 2022th, the total cumulative number of confirmed COVID-19 cases in Korea was 649,669, the death toll was 5,838, and the mortality rate was 0.89%. The Korean quarantine system hospitalizes COVID-19 patients in the early stages of the (COVID-19) disease. We believe that it is due to this system that Korea has been able to keep a considerably low death rate compared to many other countries. In this paper, with data on 2,925 patients hospitalized from March 2, 2020 to September 30, 2021 at this hospital, this paper analyzes the disease patterns of patients, by analyzing clinical features and medication history of the patients and the existing diseases of the COVID-19 patients who were hospitalized in the hospital. The important thing is that Regdanvimab (Regkirona) should administered as early as possible in the early stage of infection and Veklury (Remdesivir) also should be administered as soon as possible at the time when oxygen saturation starts to drop. It is believed that the current quarantine system in Korea, which allows patients to be treated in hospitals at the initial stage of diagnosis, lowered the death rate from COVID-19.},
 year = {2022}
}

Copy | Download

TY  - JOUR
T1  - COVID-19 Disease Clinical Manifestations and Treatment Result Analysis
AU  - Youngah Choi
AU  - Jeong-Seon Yoo
AU  - Eun-Hyang Song
AU  - Bu-Yeon Kim
AU  - Shin-Ae Park
AU  - Hyun-Joo Jin
Y1  - 2022/02/16
PY  - 2022
N1  - https://doi.org/10.11648/j.sjcm.20221101.14
DO  - 10.11648/j.sjcm.20221101.14
T2  - Science Journal of Clinical Medicine
JF  - Science Journal of Clinical Medicine
JO  - Science Journal of Clinical Medicine
SP  - 25
EP  - 32
PB  - Science Publishing Group
SN  - 2327-2732
UR  - https://doi.org/10.11648/j.sjcm.20221101.14
AB  - From March 2nd, 2020th, this hospital started as a hospital mainly for COVID-19 infections and has been continuously treating COVID-19 inpatients until now, January 5th, 2022th. From the beginning of February, 2020th, to January 5th, 2022th, the total cumulative number of confirmed COVID-19 cases in Korea was 649,669, the death toll was 5,838, and the mortality rate was 0.89%. The Korean quarantine system hospitalizes COVID-19 patients in the early stages of the (COVID-19) disease. We believe that it is due to this system that Korea has been able to keep a considerably low death rate compared to many other countries. In this paper, with data on 2,925 patients hospitalized from March 2, 2020 to September 30, 2021 at this hospital, this paper analyzes the disease patterns of patients, by analyzing clinical features and medication history of the patients and the existing diseases of the COVID-19 patients who were hospitalized in the hospital. The important thing is that Regdanvimab (Regkirona) should administered as early as possible in the early stage of infection and Veklury (Remdesivir) also should be administered as soon as possible at the time when oxygen saturation starts to drop. It is believed that the current quarantine system in Korea, which allows patients to be treated in hospitals at the initial stage of diagnosis, lowered the death rate from COVID-19.
VL  - 11
IS  - 1
ER  -

Copy | Download

Author Information

Youngah Choi

Department of Internal Medicine, Seoul Metropolitan Seobuk Hospital, Seoul, Korea
Jeong-Seon Yoo

Division of Endocrine Disease, Department of Internal Medicine, Seoul Metropolitan Seobuk Hospital, Seoul, Korea
Eun-Hyang Song

Department of Neurology, Seoul Metropolitan Seobuk Hospital, Seoul, Korea
Bu-Yeon Kim

Department of Thoracic Surgery, Seoul Metropolitan Seobuk Hospital, Seoul, Korea
Shin-Ae Park

Department of Family Medicine, Seoul Metropolitan Seobuk Hospital, Seoul, Korea
Hyun-Joo Jin

Department of Pediatrics, Seoul Metropolitan Seobuk Hospital, Seoul, Korea

Download PDF

Sections

Plain Text BibTeX RIS

APA Style

Youngah Choi, Jeong-Seon Yoo, Eun-Hyang Song, Bu-Yeon Kim, Shin-Ae Park, et al. (2022). COVID-19 Disease Clinical Manifestations and Treatment Result Analysis. Science Journal of Clinical Medicine, 11(1), 25-32. https://doi.org/10.11648/j.sjcm.20221101.14

Copy | Download

ACS Style

Youngah Choi; Jeong-Seon Yoo; Eun-Hyang Song; Bu-Yeon Kim; Shin-Ae Park, et al. COVID-19 Disease Clinical Manifestations and Treatment Result Analysis. Sci. J. Clin. Med. 2022, 11(1), 25-32. doi: 10.11648/j.sjcm.20221101.14

Copy | Download

AMA Style

Youngah Choi, Jeong-Seon Yoo, Eun-Hyang Song, Bu-Yeon Kim, Shin-Ae Park, et al. COVID-19 Disease Clinical Manifestations and Treatment Result Analysis. Sci J Clin Med. 2022;11(1):25-32. doi: 10.11648/j.sjcm.20221101.14

Copy | Download

@article{10.11648/j.sjcm.20221101.14,
  author = {Youngah Choi and Jeong-Seon Yoo and Eun-Hyang Song and Bu-Yeon Kim and Shin-Ae Park and Hyun-Joo Jin},
  title = {COVID-19 Disease Clinical Manifestations and Treatment Result Analysis},
  journal = {Science Journal of Clinical Medicine},
  volume = {11},
  number = {1},
  pages = {25-32},
  doi = {10.11648/j.sjcm.20221101.14},
  url = {https://doi.org/10.11648/j.sjcm.20221101.14},
  eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.sjcm.20221101.14},
  abstract = {From March 2nd, 2020th, this hospital started as a hospital mainly for COVID-19 infections and has been continuously treating COVID-19 inpatients until now, January 5th, 2022th. From the beginning of February, 2020th, to January 5th, 2022th, the total cumulative number of confirmed COVID-19 cases in Korea was 649,669, the death toll was 5,838, and the mortality rate was 0.89%. The Korean quarantine system hospitalizes COVID-19 patients in the early stages of the (COVID-19) disease. We believe that it is due to this system that Korea has been able to keep a considerably low death rate compared to many other countries. In this paper, with data on 2,925 patients hospitalized from March 2, 2020 to September 30, 2021 at this hospital, this paper analyzes the disease patterns of patients, by analyzing clinical features and medication history of the patients and the existing diseases of the COVID-19 patients who were hospitalized in the hospital. The important thing is that Regdanvimab (Regkirona) should administered as early as possible in the early stage of infection and Veklury (Remdesivir) also should be administered as soon as possible at the time when oxygen saturation starts to drop. It is believed that the current quarantine system in Korea, which allows patients to be treated in hospitals at the initial stage of diagnosis, lowered the death rate from COVID-19.},
 year = {2022}
}

Copy | Download

TY  - JOUR
T1  - COVID-19 Disease Clinical Manifestations and Treatment Result Analysis
AU  - Youngah Choi
AU  - Jeong-Seon Yoo
AU  - Eun-Hyang Song
AU  - Bu-Yeon Kim
AU  - Shin-Ae Park
AU  - Hyun-Joo Jin
Y1  - 2022/02/16
PY  - 2022
N1  - https://doi.org/10.11648/j.sjcm.20221101.14
DO  - 10.11648/j.sjcm.20221101.14
T2  - Science Journal of Clinical Medicine
JF  - Science Journal of Clinical Medicine
JO  - Science Journal of Clinical Medicine
SP  - 25
EP  - 32
PB  - Science Publishing Group
SN  - 2327-2732
UR  - https://doi.org/10.11648/j.sjcm.20221101.14
AB  - From March 2nd, 2020th, this hospital started as a hospital mainly for COVID-19 infections and has been continuously treating COVID-19 inpatients until now, January 5th, 2022th. From the beginning of February, 2020th, to January 5th, 2022th, the total cumulative number of confirmed COVID-19 cases in Korea was 649,669, the death toll was 5,838, and the mortality rate was 0.89%. The Korean quarantine system hospitalizes COVID-19 patients in the early stages of the (COVID-19) disease. We believe that it is due to this system that Korea has been able to keep a considerably low death rate compared to many other countries. In this paper, with data on 2,925 patients hospitalized from March 2, 2020 to September 30, 2021 at this hospital, this paper analyzes the disease patterns of patients, by analyzing clinical features and medication history of the patients and the existing diseases of the COVID-19 patients who were hospitalized in the hospital. The important thing is that Regdanvimab (Regkirona) should administered as early as possible in the early stage of infection and Veklury (Remdesivir) also should be administered as soon as possible at the time when oxygen saturation starts to drop. It is believed that the current quarantine system in Korea, which allows patients to be treated in hospitals at the initial stage of diagnosis, lowered the death rate from COVID-19.
VL  - 11
IS  - 1
ER  -

Copy | Download